RSRTI Health Solutions logo

RTI Health Solutions

Unclaimed
Healthcare ResearchServicesrtihs.orgDurham, North Carolina, United StatesUpdated

RTI Health Solutions provides research and consulting services to help life science and healthcare stakeholders make evidence-based decisions.

Overview

RTI Health Solutions is an independent, nonprofit research and consulting organization serving life science and healthcare stakeholders. Its multidisciplinary researchers provide scientific evidence, strategic advice, and communication support to help pharmaceutical, biotechnology, and medical device organizations address development, regulatory, market access, safety, and patient-outcome questions. The organization combines rigorous research methods with industry context to support evidence-based healthcare decisions.

Mission statement

To improve the human condition by turning knowledge into practice.

One of 5 AI agents in Healthcare Research

Read recently by Perplexity Meta Amazon

What we offer

Value, Access, and HEOR Consulting

Service

Helps life sciences and medtech teams demonstrate product value, navigate market access requirements, and support reimbursement decisions with evidence.

rtihs.org →

Patient-Centered Research

Service

Turns patient perspectives and preferences into evidence that supports product development, regulatory decisions, and strategic choices.

rtihs.org →

Regulatory and safety consulting

Service

Generates rigorous safety and regulatory evidence to guide product development, support submissions, and inform post-approval decisions.

rtihs.org →

Medical Communications

Service

Turns complex evidence into clear, credible communications that inform audiences, support scientific exchange, and advance understanding across the product lifecycle.

rtihs.org →

Real-world evidence research and consulting

Service

Generates and applies real-world evidence to inform product development, regulatory decisions, market access, reimbursement, and outcomes research.

rtihs.org →

Medical Affairs Solutions

Service

Aligns evidence, communications, and stakeholder engagement to support informed healthcare decisions and stronger launch and lifecycle execution.

rtihs.org →

Joint Clinical Assessment Services

Service

Prepares stronger EU JCA submissions with strategic planning, robust evidence generation, and support adapting to assessment scope and national HTA needs.

rtihs.org →

Implementation science services

Service

Anticipates adoption challenges and aligns evidence, stakeholders, and healthcare systems so innovations can reach patients in real-world practice.

rtihs.org →

Market segments

Market size by segment

Growth potential (CAGR)

Health economics and market access consulting

1.5 Billion USD13.5% CAGR

Research and consulting that help life sciences companies demonstrate clinical and economic value, prepare health technology assessments, and support pricing, reimbursement, and market access decisions.

Products: Value, Access, and HEOR Consulting, Joint Clinical Assessment Services

Real-world evidence

3.9 Billion USD11.1% CAGR

Capabilities to aggregate, link, and analyze clinical and claims data to generate evidence for clinical research, regulatory submissions, and lifecycle evidence generation.

Products: Real-world evidence research and consulting, Regulatory and safety consulting, Value, Access, and HEOR Consulting

Patient-centered outcomes research

1.5 Billion USD13.5% CAGR

Research that helps product developers incorporate patient perspectives, develop and validate clinical outcome assessments, quantify treatment preferences, and support regulatory claims and benefit-risk decisions.

Products: Patient-Centered Research, Regulatory and safety consulting

Regulatory affairs and drug safety consulting

7 Billion USD8.5% CAGR

Scientific and strategic support for life sciences companies preparing regulatory submissions, engaging agencies, assessing benefit-risk, and meeting post-authorization safety and evidence requirements.

Products: Regulatory and safety consulting, Real-world evidence research and consulting

Medical affairs and scientific communications

6.99 Billion USD5.8% CAGR

Services that help life sciences teams plan medical strategy, communicate scientific evidence, educate and engage stakeholders, and address implementation barriers to product adoption across the lifecycle.

Products: Medical Affairs Solutions, Medical Communications, Implementation science services

More information about our offering

Value, Access, and HEOR Consulting

RTI Health Solutions provides value, access, and HEOR consulting and research for pharmaceutical, biotechnology, and medtech companies. Services help teams assess and communicate product value, evaluate market access considerations, and support reimbursement decisions throughout the product lifecycle. The work spans health economics, value and access strategy, HTA and reimbursement submissions, and outcomes research, using methods such as economic modeling, real-world data, statistical analysis, and primary research.

  • Assess Value And Inform Economic Decisions
    Builds evidence-based assessments of product value to inform healthcare decisions, market access, reimbursement, and HTA submissions.
  • Develop Submissions For Global Market Access
    Helps pharmaceutical and medtech companies prepare submissions and dossiers that demonstrate product value, meet payer needs, and address global market access requirements.
  • Guide Product Value And Access Planning
    Supports clinical and commercial teams in shaping evidence-based strategies and tactics to communicate product value and pursue market access.
  • Present Evidence To Healthcare Decision-Makers
    Provides structured, evidence-based dossiers that communicate product value to stakeholders and support payer formulary decisions.
  • Identify Evidence Needs For Reimbursement
    Clarifies where additional evidence generation can support reimbursement decisions and improve product access.
  • Communicate Product Value To Relevant Audiences
    Turns research findings and value messages into communication materials intended to support understanding and adoption by relevant audiences.
  • Understand Decision-Maker Perspectives
    Surfaces expert and stakeholder perspectives that can inform pricing, reimbursement, access, evidence planning, and product strategy.
  • Evaluate Real-World Product Outcomes
    Provides evidence about how products are used and their value and safety in real-world settings to inform product and healthcare decisions.
  • Synthesize Evidence And Identify Gaps
    Brings together existing research to clarify what is known, reveal evidence gaps, and support development and healthcare decisions.
  • Generate Evidence Across Research Questions
    Uses a range of research methods and data sources to address questions about product development, market access, reimbursement, treatment effectiveness, and healthcare decision-making.
  • Address Pricing And ICER Considerations
    Supports product value and pricing considerations in relation to ICER's evolving landscape.
  • Address Equity Across The Product Lifecycle
    Integrates health equity considerations with innovation across the pharmaceutical lifecycle.

Patient-Centered Research

RTI Health Solutions’ patient-centered research services capture, quantify, and apply the patient perspective throughout the product lifecycle. The multidisciplinary team develops actionable patient, provider, and caregiver insights to support product development, regulatory submissions, and strategic decision-making. Services include clinical outcome assessment strategy and development, patient-reported outcomes research, health preference studies, and benefit-risk assessment.

  • Apply Patient Perspectives To Decisions
    Uses actionable insights from patients, providers, and caregivers to inform product development, regulatory submissions, and strategic decisions.
  • Align Outcomes With Patient And Regulatory Needs
    Develops a clinical outcome assessment strategy that reflects patient experience while aligning with regulatory requirements.
  • Develop And Validate Outcome Measures
    Creates or adapts outcome measures that reflect patient experiences and support product approval and labeling claims.
  • Quantify Patient Treatment Preferences
    Clarifies patient priorities and treatment trade-offs to inform product development, positioning, and regulatory decisions.
  • Capture Patient Outcomes Across Research Settings
    Collects patient-reported information in clinical trials, observational studies, and clinical practice to support product claims, market access, and patient-clinician communication.
  • Balance Product Benefits And Risks
    Assesses product benefits and risks in a way that addresses regulatory, reimbursement, and healthcare provider needs.
  • Identify Evidence Gaps
    Reviews existing scientific findings to clarify what is known, identify gaps, and inform development decisions.

Regulatory and safety consulting

RTI Health Solutions provides scientifically rigorous regulatory and safety consulting for pharmaceutical, biotech, and medical device companies. Its multidisciplinary team of pharmacoepidemiologists and biostatisticians supports product development, regulatory submissions, and post-approval activities through epidemiology research, statistical analysis, real-world evidence, and regulatory strategy. Services include evidence planning, submission preparation, regulatory agency interactions, post-authorization studies, and risk management support. Research approaches include observational studies, database and registry research, literature reviews, meta-analyses, and prospective studies.

  • Assess Disease Patterns And Treatment Impact
    Uses epidemiologic research to examine disease indicators, treatment impact, and patient outcomes, supporting development, regulatory submissions, and post-market safety activities.
  • Navigate Regulatory Requirements And Submissions
    Provides strategic and scientific guidance for evidence requirements, submission preparation, and regulatory agency interactions throughout product development and after authorization.
  • Analyze Data For Regulatory Decisions
    Applies statistical methods and tools to clinical trial and observational data to generate evidence for regulatory, safety, and market access decisions.
  • Strengthen Post-Approval Safety Evidence
    Generates evidence about product safety and effectiveness after authorization while supporting regulatory obligations and post-approval strategies.
  • Apply Real-World Evidence Across Development
    Develops an approach to using real-world data at different stages of product development and supports regulatory decision-making and post-approval activities.
  • Develop And Support Outcome Measures
    Develops or revises outcome measures and supporting evidence with attention to regulatory agency expectations and their use in clinical trials and labeling strategies.
  • Evaluate Product Benefits And Risks
    Assesses product benefits and risks to inform regulatory and healthcare decisions and address reimbursement and provider needs.
  • Plan And Coordinate Rigorous Studies
    Assesses study feasibility, develops scientifically rigorous and regulatorily aligned protocols, and coordinates pharmacoepidemiologic investigations from planning through delivery.
  • Combine Data And Research Expertise
    Draws on research collaborations and multi-country real-world data to produce rigorous, transparent evidence supporting safety and effectiveness insights.

Medical Communications

RTI Health Solutions provides medical communications consulting and engagement strategy to translate complex clinical and scientific evidence into clear, audience-appropriate communications. Services span strategic planning, integrated evidence strategy, expert research, medical writing and publication planning, medical education, and creative and digital solutions. Multidisciplinary teams develop customized, scientifically rigorous communications for healthcare and scientific audiences, including providers, patients, and families, across the product lifecycle.

  • Align Evidence Across The Product Lifecycle
    Connects evidence planning and execution with communication expertise to support continuity of outcomes throughout the product lifecycle.
  • Communicate Research With Clarity And Credibility
    Supports publication goals and communicates research to the right audiences through tailored writing, editing, and publication materials.
  • Make Scientific Data Clear And Engaging
    Presents accurate scientific information through audience-focused design and digital experiences intended to help audiences understand, remember, and act on the data.
  • Tailor Evidence To Audience Needs
    Adapts scientific communications to the intended audience so complex evidence is presented clearly and appropriately.
  • Inform Strategy With Stakeholder Perspectives
    Uses targeted research to understand stakeholder beliefs, competitor positioning, and evidence needs, and translates those insights into strategies.
  • Turn Complex Evidence Into Practical Learning
    Supports disease understanding, contextualizes emerging data, and promotes knowledge retention and practical application through education formats.
  • Support Meaningful Scientific Exchange
    Plans audience engagement across formats such as congresses, advisory boards, field medical interactions, and digital education.
  • Measure And Refine Communication Impact
    Uses analytics to assess communication impact and inform refinements to creative and digital solutions.

Real-world evidence research and consulting

RTI Health Solutions provides real-world evidence research and consulting to pharmaceutical, biotech, and medical device companies throughout the product lifecycle. Its services include evidence strategy, database and registry research, primary data collection, and research collaborations. The team develops research approaches using real-world data to support product development, regulatory decision-making, market access, reimbursement, safety activities, and outcomes research.

  • Guide Evidence Generation Across The Product Lifecycle
    Helps organizations determine how to use real-world data to address research questions and support decisions at different stages of product development and use.
  • Turn Real-World Data Into Actionable Evidence
    Enables research using database and registry sources to address questions about treatments, diseases, healthcare resource use, and patient outcomes.
  • Align Evidence Approaches With Regulatory Needs
    Helps clients interpret relevant real-world evidence guidelines and plan research approaches for development, regulatory decision-making, and post-authorization activities.
  • Capture Evidence From Patients And Care Teams
    Supports observational research that gathers information directly through cohort studies and surveys involving patients, physicians, or caregivers.
  • Combine Data And Expertise Across Research Partners
    Research partnerships support multi-country studies and evidence generation on treatment safety and effectiveness, with an emphasis on methodological rigor and transparency.
  • Support Post-Authorization Safety And Evidence Needs
    Provides study support to address safety, efficacy validation, and regulatory obligations after a product has been authorized.
  • Evaluate Treatments With Real-World Comparators
    Supports treatment evaluation by developing external control arm analyses using real-world evidence, including for single-arm trial comparators.
  • Design Rigorous Studies For Research Objectives
    Helps translate research questions into study designs and protocols intended to meet scientific and regulatory requirements while considering project constraints.
  • Use Clinical Records To Address Research Questions
    Helps clients study clinical chart information as part of real-world research, including when special data protections are required.
  • Assess Study Feasibility Before Research Begins
    Provides information on practical study requirements and constraints, including timelines, costs, patient availability, and data source reliability.
  • Coordinate Pharmacoepidemiology Studies From Planning To Delivery
    Supports study execution by coordinating pharmacoepidemiologic investigations across their planning and delivery stages.
  • Measure Health And Treatment Patterns Over Time
    Uses cross-sectional and longitudinal surveys to describe current disease and treatment patterns or examine changes in health, treatment response, and outcomes.
  • Apply Target Trial Emulation To Real-World Data
    Uses the target trial emulation framework to support real-world data analysis and address methodological challenges.
  • Combine Clinical Assessments With Patient Insights
    Brings together in-person clinical assessments and structured survey information in observational research.

Medical Affairs Solutions

RTI Health Solutions provides patient-centered medical affairs strategy and services to support evidence-based healthcare decisions and scientific exchange across the product lifecycle. Its multidisciplinary offerings include integrated evidence planning, expert and stakeholder research, medical education, scientific communications, launch readiness, and digital engagement. The work aligns evidence narratives, stakeholder needs, and global and local activities to help scientific innovations reach the right patients in the right context.

  • Plan And Generate Integrated Evidence
    Connects evidence planning with design, generation, delivery, and communication to support continuity of outcomes throughout the product lifecycle.
  • Shape Evidence-Based Medical Strategy
    Develops medical strategy and positioning that reflect evidence and stakeholder needs, supporting healthcare decisions and scientific exchange.
  • Uncover Stakeholder Perspectives
    Gathers perspectives from experts, payers, providers, and other stakeholders through primary research and mapping to inform evidence plans and strategy.
  • Translate Evidence Into Practical Learning
    Creates clear, interactive learning experiences intended to promote knowledge retention and practical application, support disease understanding, and inform decisions across the care pathway.
  • Support Launch And Lifecycle Readiness
    Coordinates medical affairs planning and execution to support product launch and ongoing lifecycle activities.
  • Communicate Scientific Evidence Clearly
    Turns complex evidence into audience-appropriate scientific communications and content to support understanding and meaningful scientific exchange.
  • Align Global, Local, And Cross-Functional Teams
    Connects global and local activities and facilitates cross-functional alignment to support coordinated medical affairs planning and execution.
  • Plan And Deliver Scientific Publications
    Coordinates publication activities and related content to communicate evidence as part of a broader medical affairs strategy.
  • Create Engaging Congress Experiences
    Plans congress activities and develops booth designs and interactives to support scientific engagement with stakeholders.
  • Engage Stakeholders And Track Impact
    Uses online platforms and digital engagement approaches to connect with stakeholders, with metrics and reporting to assess and refine impact.
  • Assess Landscape And Competitors
    Uses landscape and competitor intelligence to inform medical strategy, positioning, and planning.
  • Understand Patient Journeys And Sentiment
    Uses patient journey and social sentiment analysis to inform medical affairs planning and stakeholder engagement.

Joint Clinical Assessment Services

RTI Health Solutions provides strategic and technical support to help drug and device developers prepare for and navigate the EU Joint Clinical Assessment process. Services span early planning, submission strategy, evidence generation and synthesis, and dossier preparation. The team helps anticipate assessment scope, address JCA and national HTA interdependencies, and develop robust evidence strategies aligned with stakeholder needs.

  • Build A Prepared Submission Strategy
    Develops a JCA strategy and preparatory activities for different assessment scenarios, with early consideration of scope, evidence needs, consultation, and organizational readiness.
  • Generate Submission-Ready Evidence
    Develops scientifically rigorous evidence for JCA submissions and a credible value story while addressing methodological requirements and stakeholder evidence needs.
  • Anticipate Assessment Scope
    Prepares for likely and appropriate PICOs before final scope is confirmed, enabling focused evidence generation and planning for potential scope or label changes.
  • Prepare And Refine JCA Dossiers
    Builds submission readiness through advance preparation and dossier refinement, with support to adapt materials when final scope or label changes.
  • Align Evidence Across Requirements
    Plans evidence generation with JCA and national HTA requirements in view, helping teams coordinate their approach across stakeholder needs.
  • Gather Coordinated Multi-Country Input
    Obtains coordinated input on clinical development plans before pivotal trial parameters are finalized, with support that can include mock consultations.
  • Assess Readiness And Train Teams
    Evaluates organizational readiness and provides training to help teams prepare for JCA requirements and submission activities.

Implementation science services

RTI Health Solutions provides multidisciplinary implementation science services to help pharmaceutical, biotech, and medtech companies bridge the gap between clinical development and real-world healthcare adoption. The team combines insights from clinical research, Medical Affairs, real-world evidence, health economics, and stakeholder engagement in a systems-thinking approach. Using established frameworks and rigorous analytics, they identify factors that support or hinder adoption and develop tailored strategies that connect scientific evidence, market dynamics, provider practices, patient perspectives, and policy environments.

  • Identify Adoption Barriers Early
    Pinpoints factors that may prevent providers, patients, payers, or health systems from adopting a therapy, allowing teams to address real-world challenges proactively.
  • Align Teams Around Adoption
    Connects expertise and perspectives across relevant functions so implementation considerations are addressed together rather than in silos.
  • Plan For Uptake Before Launch
    Considers real-world adoption during development, giving teams the opportunity to use implementation needs to shape evidence generation and care pathway planning before launch.
  • Tailor Strategies To Real-World Needs
    Translates findings about adoption conditions into strategies designed for the specific product and its stakeholder, market, and healthcare system context.
  • Connect Evidence And Care Systems
    Addresses relationships among evidence, stakeholders, market conditions, and healthcare systems to develop implementation strategies suited to the real-world context.

Sources

Methodology and sourcing behind the figures and links shown above.

Health economics and market access consulting

The closest available estimate is the global HEOR market: USD 1.50 billion in 2024, projected to grow at a 13.50% CAGR through 2034. This market includes services beyond consulting, so it is a proxy and may overstate the consulting-only segment.

Real-world evidence

Estimated global market size is USD 3.9 billion in 2025, using Grand View Research’s estimate for real-world evidence solutions, which closely matches the described capabilities. Published estimates vary across providers and market definitions; reported growth rates range from 11.1% to 16.3%. The estimate uses Grand View Research’s 2026–2033 forecast CAGR of 11.1%.

Patient-centered outcomes research

The search results provide no standalone estimate for patient-centered outcomes research. The closest quantified proxy is the broader global health economics and outcomes research (HEOR) market, valued at USD 1.50 billion in 2024 and forecast to grow at 13.50% CAGR through 2034. Because the specified segment is narrower than HEOR, USD 1.50 billion should be treated as a broad-market proxy, not a direct segment estimate; the segment's actual size is likely smaller.

Regulatory affairs and drug safety consulting

Estimated global 2025 market for regulatory affairs and drug-safety consulting. The estimate uses the reported USD 5 billion 2025 regulatory consulting market as an anchor, adjusted upward for drug-safety consulting; broader regulatory affairs and pharmacovigilance market figures provide context but include activities beyond consulting. Growth is estimated at 8.5%, consistent with reported regulatory consulting, regulatory affairs, and pharmacovigilance growth rates.

Medical affairs and scientific communications

The medical communication services estimate is the closest available proxy for this broader segment, covering scientific communication and related services. It reports a 2026 market size of USD 6.994 billion and a 5.8% CAGR through 2034. Medical writing is a related component, with separate estimates around USD 5.3–5.7 billion, so these figures should not be added to the proxy. The segment estimate is therefore approximate and may not capture all medical strategy and affairs services.

Behind this page

This is a public preview. Whoever claims it decides what it shows.

This page was built from public information. Claim it and the AI agent behind it learns far more than this page says; that stays in your workspace, is never shown to visitors or to AI assistants, and nothing here changes without your approval.

Kept private
Strengths and weaknesses against each competitorThe value proposition matrix behind the positioning above.
BattlecardsHow to win against a named competitor, persona by persona.
AI visibility and citationsWhere assistants mention RTI Health Solutions, where they don't, and who they cite instead.
Site audit, keyword rankings and recommendationsWhat to fix so AI ranks RTI Health Solutions higher.

Own this company? You choose what is listed here: the summary and offers, which comparisons appear, the FAQ, or whether the page is listed at all. Unlisting takes one switch.

Built from public web sources. Request removal →